Evidence map›Paper›PMID 35127723›Full record

ArticleFrontiers in cell and developmental biology2021

Human Umbilical Cord Mesenchymal Stem Cells Improve Locomotor Function in Parkinson's Disease Mouse Model Through Regulating Intestinal Microorganisms.

Zhengqin Sun, Ping Gu, Hongjun Xu, Wei Zhao, Yongjie Zhou, Luyang Zhou, Zhongxia Zhang, Wenting Wang, Rui Han, Xiqing Chai and 1 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in cell and developmental biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
7.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 53 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Zhengqin SunDepartment of Neurology, The First Hospital of Hebei Medical University, Shijiazhuang, China.
Ping GuDepartment of Neurology, The First Hospital of Hebei Medical University, Shijiazhuang, China.
Hongjun XuHebei Provincial Engineering Laboratory of Plant Bioreactor Preparation Technology, Shijiazhuang, China.
Wei ZhaoHebei Provincial Engineering Laboratory of Plant Bioreactor Preparation Technology, Shijiazhuang, China.
Yongjie ZhouHebei Provincial Engineering Laboratory of Plant Bioreactor Preparation Technology, Shijiazhuang, China.
Luyang ZhouHebei Provincial Engineering Laboratory of Plant Bioreactor Preparation Technology, Shijiazhuang, China.
Zhongxia ZhangDepartment of Neurology, The First Hospital of Hebei Medical University, Shijiazhuang, China.
Wenting WangDepartment of Neurology, The First Hospital of Hebei Medical University, Shijiazhuang, China.
Rui HanDepartment of Neurology, The First Hospital of Hebei Medical University, Shijiazhuang, China.
Xiqing ChaiDepartment of Neurology, The First Hospital of Hebei Medical University, Shijiazhuang, China.
Shengjun AnHebei Provincial Engineering Laboratory of Plant Bioreactor Preparation Technology, Shijiazhuang, China.
Hebei University of Chinese Medicine · CNFirst Affiliated Hospital of Hebei Medical University · CNHebei Medical University · CNAffiliated Hospital of Hebei University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Parkinson's disease (PD) is a progressive neurological disorder characterized by loss of neurons that synthesize dopamine, and subsequent impaired movement. Umbilical cord mesenchymal stem cells (UC-MSCs) exerted neuroprotection effects in a rodent model of PD. However, the mechanism underlying UC-MSC-generated neuroprotection was not fully elucidated. In the present study, we found that intranasal administration of UC-MSCs significantly alleviated locomotor deficits and rescued dopaminergic neurons by inhibiting neuroinflammation in a PD mouse model induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP, a toxic agent which selectively destroys nigrostriatal neurons but does not affect dopaminergic neurons elsewhere). Furthermore, UC-MSC treatment altered gut microbiota composition characterized by decreased phylum Proteobacteria, class Gammaproteobacteria, family Enterobacteriaceae, and genus

Indexed as

goblet cellsgut microbiotahuman umbilical cord mesenchymal stem cellsinflammationneurotransmitterParkinson’s disease (PD)

Identifiers

PMID35127723
PMCPMC8810651
OpenAlexW4206156995

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.